Foresight invests £2.5m in ABL

The deal marks the 10th investment by the GP's Foresight Regional Investment Fund, which recently reached a final close on £57m.

Foresight's equity investment is supported by a debt package from Barclays and will help boost the company's geographic expansion plans, in addition to widening its service offering across both the public and private sectors.

Co-founder Denise Leslie will continue to lead the business as CEO, with co-founder Sheena Bedi becoming a non-executive director to provide clinical input. In addition, Foresight introduced Chris Jessop as chair; he has held senior leadership roles at Optima Health, Nuffield Wellbeing, Bupa and Axa PPP.

Company
Founded in 2009 and headquartered in Bolton, ABL is a provider of community healthcare and wellbeing services across the north of England. The company claims it has helped around 12,000 clients record weight loss in the north-west region.

The company operates from its premises in Bolton, Lancashire, within the grounds of the Royal Bolton Hospital, as well as satellite offices in Manchester, Stockport, Wirral, St Helens and Hull. It employs a staff of 200.

People
Foresight Group – Matthew Pomroy (investment manager).
ABL Health – Denise Leslie (CEO, co-founder).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• UK / Ireland
• Healthcare
• United Kingdom
• Foresight Group